Pfizer and BioNTech announce trials of new Omicron jab
Published
Pfizer and BioNTech have adapted their original vaccine to target the fast-spreading variant.
Full ArticlePublished
Pfizer and BioNTech have adapted their original vaccine to target the fast-spreading variant.
Full ArticleThe companies have adapted their original vaccine to target the fast-spreading variant.
Pfizer and partner BioNTech SE are working on both an Omicron-targeted vaccine variant as well as a shot that would include both..